Subsequently, we attempted to ascertain the ability of ERCs to inhibit lung fibrosis and to study whether its underlying mechanism was associated with the vital factor TGF-β, which functions as a central regulator in promoting fibrosis. The gene discussed is TGFB1; the disease is pulmonary fibrosis.